Vladlena A Tiasto

Dr. Vladlena A Tiasto

Institute of Life Sciences and Biomedicine, Far Eastern Federal University, Vladivostok, Primorskiy Kray, Russia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
MKMaksim Khotimchenko
Maksim Khotimchenko
Vladlena A TiastoVladlena A Tiasto
Vladlena A Tiasto
AKAleksandra Kalitnik
Aleksandra Kalitnik
MBMaria Begun
Maria Begun
RKRodion Khotimchenko
Rodion Khotimchenko
YKYuri Khotimchenko
Yuri Khotimchenko

26 June 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
ABArtem Blagodatski
Artem Blagodatski
MYMargarita Yatsunskaya
Margarita Yatsunskaya
VMValeriia Mikhailova
Valeriia Mikhailova
Vladlena A TiastoVladlena A Tiasto
Vladlena A Tiasto
AKAlexander Kagasky
Alexander Kagasky
Vladimir KatanaevVladimir Katanaev
Vladimir Katanaev
Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy

13 October 2019 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
ECEduardas Cicinskas
Eduardas Cicinskas
MBMaria A. Begun
Maria A. Begun
Vladlena A TiastoVladlena A Tiasto
Vladlena A Tiasto
ABAndrei Belousov
Andrei Belousov
VVValeria V. Vikhareva
Valeria V. Vikhareva
AKAleksandra Kalitnik
Aleksandra Kalitnik

25 November 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Vladlena A TiastoVladlena A Tiasto
Vladlena A Tiasto
NGNikolay V Goncharov
Nikolay V Goncharov
ARAlexander Romanishin
Alexander Romanishin
Maxim E. ZhidkovMaxim E. Zhidkov
Maxim E. Zhidkov
YKYuri Khotimchenko
Yuri Khotimchenko
The carrageenans isolated from red algae demonstrated a variety of activities from antiviral and immunomodulatory to antitumor. The diverse structure and sulfation profile of carrageenans provide a great landscape for drug development. In this study, we isolated, purified and structurally characterized κo- and λo- oligosaccharides from the marine algae Chondrus armatus. We further examined the tumor suppressive activity of both carrageenans in gastrointestinal cancer models. Thus, using MTT assay, we could demonstrate a pronounced antiproliferative effect of the carrageenans in KYSE-30 and FLO-1 as well as HCT-116 and RKO cell lines with IC50 184~405 μg/mL, while both compounds were less active in non-cancer epithelial cells RPE-1. This effect was stipulated by the inhibition of cell cycle progression in the cancer cells. Specifically, flow cytometry revealed an S phase delay in FLO-1 and HCT-116 cells under κo-carrageenan treatment, while KYSE-30 demonstrated a pronounced G2/M cell cycle delay. In line with this, western blotting revealed a reduction of cell cycle markers CDK2 and E2F2. Interestingly, κo-carrageenan inhibited cell cycle progression of RKO cells in G1 phase. Finally, isolated κo- and λo- carrageenans induced apoptosis on adenocarcinomas, specifically with high apoptosis induction in RKO cells. Overall, our data underline the potential of κo- and λo- carrageenans for colon and esophageal carcinoma drug development.

1 August 2018 in AIMS Genetics
Verified
Journal Article
Open access
VMValeriia Mikhailova
Valeriia Mikhailova
VGValeriia Gulaia
Valeriia Gulaia
Vladlena A TiastoVladlena A Tiasto
Vladlena A Tiasto
SRStanislav A. Rybtsov
Stanislav A. Rybtsov
MYMargarita Yatsunskaya
Margarita Yatsunskaya
AKAlexander Kagasky
Alexander Kagasky
The modulation of tumor growth and development in vitro has always been one of the key factors in the research of the malignant transformation, including gliomas, prevalent and most deadly cancers of the brain. Indeed, cellular and molecular biology research employing in vitro model cell-based systems have great potential to advance both the mechanistic understanding and the treatment of human glial tumors, as it facilitates not only the understanding of glioma biology and its regulatory mechanisms Additionally they promise to afford the screening of the putative anti-tumor agents and alternative treatment approaches in a personalized manner, i.e. by virtue of using the patient-derived tumor material for such tests. However, in order to become reliable and representative, glioma model systems need to move towards including most inherent cancer features such as local hypoxia, specific genetic aberrations, native tumor microenvironment, and the three-dimensional extracellular matrix. This review starts with a brief introduction on the general epidemiological and molecular characteristics of gliomas followed by an overview of the cell-based in vitro models currently used in glioma research. As a conclusion, we suggest approaches to move to innovative cell-based in vitro glioma models. We consider that main criteria for selecting these approaches should include the adequate resemblance to the key in vivo characteristics, robustness, cost-effectiveness and ease to use, as well as the amenability to high throughput handling to allow the standardized drug screening.

10 May 2018 in AIMS Genetics
Verified
Journal Article
Open access
Vladlena A TiastoVladlena A Tiasto
Vladlena A Tiasto
VMValeriia Mikhailova
Valeriia Mikhailova
VGValeriia Gulaia
Valeriia Gulaia
VVValeriia Vikhareva
Valeriia Vikhareva
BZBoris Zorin
Boris Zorin
AKAlexander Kagasky
Alexander Kagasky
Esophageal cancer is an increasing concern due to poor prognosis, aggressive disease modalities, and a lack of efficient therapeutics. The two types of esophageal cancer: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) are responsible for an estimated 450,000 annual deaths, with over 457,000 new patients diagnosed in 2015, making it the eighth most prevalent and the 10th most fatal cancer worldwide. As esophageal cancer prevalence continues to increase, and so does the pressing need for the development of new and effective strategies for the early diagnostics, prevention, and treatment of this cancer, as well for building the innovative research tools to understand the affected molecular mechanisms.This short review summarizes the current statistics and recent research of the problems and solutions related to the esophageal cancer, and offer a brief overview of its epidemiology, molecular alterations, and existing biomedical tools. We will discuss currently available research tools and discuss selected approaches we deem relevant to find new model systems and therapies for the future with the special focus on novel opportunities presented by the unique molecules found in algae, namely carbohydrates and lipids. Their remarkable chemical variability is connected to their striking structural and functional properties, which combined with the relative novelty of these compounds to cancer biology, warrants interest of the wide biomedical community to these molecules, especially in the esophageal cancer theory and practice.